M3 group joins medirom mother labs' series a financing round at jpy9 billion (as of december 1, 2024, approximately usd $59,000,000) pre-money valuation

Tokyo, dec. 02, 2024 (globe newswire) -- medirom healthcare technologies inc. (nasdaq: mrm) (“medirom”) announces that m3, inc. (tokyo prime: 2413), or an affiliate within the m3 group, is participating in the series a equity financing round of medirom mother labs inc., a subsidiary of medirom. nfes technologies inc. is the lead investor of the series a financing round at a pre-money valuation of jpy9 billion. additional information is available here: https://medirom.co.jp/en/ir/20240824/6148%09
MRM Ratings Summary
MRM Quant Ranking